Top 50 Most Viewed Posts This Week |
Today This Week Last Week This Month Last Month
|
1. grow: Long-acting Leronlimab poster also at the (951) (13) |
2. KenChowder: New RECOVER (Long Covid) Phase announced So far, (859) (9) |
3. KenChowder: HHI, I'd say you're right. Dr. Jay said the LATCH (772) (5) |
4. My69z: Nice!! & Dr. Sacha is funded to 2027 on the AAV. (683) (5) |
5. biloxiblues: From Reddit over the weekend Lalezari On The Move (652) (7) |
6. My69z: He said a while back NIH told him they wanted to (628) (2) |
7. HouseofCards: From the FB group, a new publication was posted (624) (7) |
8. dfwl28: Compliments to the board. On a nice slow week end (614) (5) |
9. grow: abstract released today (601) (24) |
10. My69z: https://stocktwits.com/Fredsavage911/message/5802 (594) (5) |
11. My69z: Also Maraviroc and BMS-813160: BMS-813160 (580) (6) |
12. HHIGambler: I disagree with their opinion that other trials (572) (11) |
13. MJS719: Here's the write up: PROJECT SUMMARY With the (560) (14) |
14. sean007: I got FIFTEEN frowns for my last Post...God it (537) (3) |
15. KenChowder: I may not be reading the abstract right. Yes, (526) (11) |
16. Riztheinvestor: Justin Stebbing is a very big player in oncology (525) (2) |
17. My69z: Detailed AAV info --- (513) (1) |
18. biloxiblues: https://www.reddit.com/r/Livimmune/comments/1eb5p (504) (6) |
19. Evil Rabbit: Relax. It’s a running harmless joke that his (504) (8) |
20. Infinitehealthwealth: $GRLF at a extreme low 0001-0002 easy 20 bagger (504) (2) |
21. My69z: & Plotinus, Maraviroc -- how about that last (503) (5) |
22. My69z: & the "safety" of the drugs: Cetuximab: An (502) (6) |
23. Drano: Hang on, let me see how many vials I have in the (501) |
24. Plotinus: As a clinician his primary interest is the best (500) (14) |
25. MJS719: I would gander a view that this was highly (498) (8) |
26. Katangolo: I taught HIV Education in Southern Africa in the (494) (12) |
27. grow: AAV research 2022 press release, plus 2024 (486) (3) |
28. HHIGambler: SEC Filing Alert SC TO-I/A: Issuer tender offer (484) (5) |
29. MGK_2: So, in the experiment, they took 4 monkeys (481) (13) |
30. grow: That's it in a nutshell. All having good results, (476) (5) |
31. Plotinus: The FDA doesn’t slap a black box warning on the (476) (8) |
32. Infinitehealthwealth: $GRLF at a extreme low 0001-0002 easy 20 bagger (472) (1) |
33. Riztheinvestor: Also this is being updated. (471) (2) |
34. My69z: Yea, that's a F'kd up (467) (2) |
35. sean007: In addition...Dr Jay removed himself from the (465) (2) |
36. sean007: Competing interests are all over this publication (465) (3) |
37. My69z: Dam good 1st read-out results. (456) (2) |
38. docj: One of my favorite bands although a few of the (455) |
39. My69z: The 2 FDA CRISPR drugs --- if LL expands into AAV (451) (3) |
40. Evil Rabbit: Now let’s get some mainstream international (450) (3) |
41. sean007: ER...please provide an example of Tanya's (450) (3) |
42. My69z: Agree 100%. Anything FDA approves ahead of any (439) (1) |
43. Evil Rabbit: Just a hunch so I’ll retract my comment. I’m (437) (3) |
44. Cycl2R: Remember in 2019, the FDA was embarrassed by (434) (2) |
45. sean007: "Why did those antibodies not return"... Our DNA (432) (4) |
46. Evil Rabbit: Here you go. (418) (1) |
47. My69z: & LL goes into muscle tissue ---- (415) (3) |
48. Figgs: The question is does Dr. JL have a friend in the (409) (1) |
49. sean007: Couldn't happen...to a nicer (407) (5) |
50. My69z: " However, some researchers have warned that gene (400) (1) |